Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Related Posts
Shah PD, Yeremian S, Forte E, Park D, Choi E, Qi J, Nguyen A, Akhtari M. EXPRESS: A Meta-analysis Reporting the Most Common Infectious Complications[...]
Hoque A, Barforoshi S, Megowan N. Giant Coronary Artery Aneurysm at the Left Main Bifurcation Managed With Stent-Assisted Endovascular Coil Embolization. JACC Case Rep. 2026[...]
Guterman EL, Dulaney SA, Sawyer RJ, Hanson LR, Olney N, Hess M, Lum HD, Brickell E, Rosenbloom M, Ward KT, Wood AJ, Allen IE, Scheffler[...]